Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells

Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2025-02, Vol.156 (3), p.638
Hauptverfasser: Wang, Ruonan, Hu, Mengwen, Lozzi, Isis, Jin, Cao Zhong Jing, Ma, Dou, Splith, Katrin, Mengwasser, Jörg, Wolf, Vincent, Feldbrügge, Linda, Tang, Peter, Timmermann, Lea, Hillebrandt, Karl Herbert, Kirchner, Marieluise, Mertins, Philipp, Hilfenhaus, Georg, Neumann, Christopher Claudius Maximilian, Kammertoens, Thomas, Pratschke, Johann, Malinka, Thomas, Sauer, Igor Maximillian, Noessner, Elfriede, Guo, Zong Sheng, Felsenstein, Matthäus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 638
container_title International journal of cancer
container_volume 156
creator Wang, Ruonan
Hu, Mengwen
Lozzi, Isis
Jin, Cao Zhong Jing
Ma, Dou
Splith, Katrin
Mengwasser, Jörg
Wolf, Vincent
Feldbrügge, Linda
Tang, Peter
Timmermann, Lea
Hillebrandt, Karl Herbert
Kirchner, Marieluise
Mertins, Philipp
Hilfenhaus, Georg
Neumann, Christopher Claudius Maximilian
Kammertoens, Thomas
Pratschke, Johann
Malinka, Thomas
Sauer, Igor Maximillian
Noessner, Elfriede
Guo, Zong Sheng
Felsenstein, Matthäus
description Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56 NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56 CD16 population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_39400317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>39400317</sourcerecordid><originalsourceid>FETCH-pubmed_primary_394003173</originalsourceid><addsrcrecordid>eNqFj11Ow0AMhFdIiJafKyBfINIuaaj6HEAcgPfKOFthuj-R1wnkONyURYVnnmakmfksn5m1s7ttY-9ctzKXpbxb61xnNxdm1e421rZuuzZf_aL5yMk3KNEPMCMRJ0aYWaYCo-SY1RegWtP8ycS6gOYPlAFGTCQelQkIpc5yRCAfQqlrBCTluaY5QT7A2xQxASf1P3cYZYH-obuHgWM17mQS6iQY4MgheDmxrs35AUPxN796ZW6fHl_652acXitpPwrHStv__dT-W_gGZWFalw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</creator><creatorcontrib>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</creatorcontrib><description>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56 NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56 CD16 population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</description><identifier>EISSN: 1097-0215</identifier><identifier>PMID: 39400317</identifier><language>eng</language><publisher>United States</publisher><subject>Carcinoma, Pancreatic Ductal - immunology ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Carcinoma, Pancreatic Ductal - virology ; CD56 Antigen - metabolism ; Cell Line, Tumor ; Coculture Techniques ; Cytotoxicity, Immunologic ; Humans ; Interleukin-15 - metabolism ; Interleukin-2 - metabolism ; Killer Cells, Natural - immunology ; Killer Cells, Natural - metabolism ; Oncolytic Virotherapy - methods ; Oncolytic Viruses - immunology ; Pancreatic Neoplasms - immunology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - virology ; Tumor Microenvironment - immunology ; Vaccinia virus - immunology</subject><ispartof>International journal of cancer, 2025-02, Vol.156 (3), p.638</ispartof><rights>2024 The Author(s). International Journal of Cancer published by John Wiley &amp; Sons Ltd on behalf of UICC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-3146-8717</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39400317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Hu, Mengwen</creatorcontrib><creatorcontrib>Lozzi, Isis</creatorcontrib><creatorcontrib>Jin, Cao Zhong Jing</creatorcontrib><creatorcontrib>Ma, Dou</creatorcontrib><creatorcontrib>Splith, Katrin</creatorcontrib><creatorcontrib>Mengwasser, Jörg</creatorcontrib><creatorcontrib>Wolf, Vincent</creatorcontrib><creatorcontrib>Feldbrügge, Linda</creatorcontrib><creatorcontrib>Tang, Peter</creatorcontrib><creatorcontrib>Timmermann, Lea</creatorcontrib><creatorcontrib>Hillebrandt, Karl Herbert</creatorcontrib><creatorcontrib>Kirchner, Marieluise</creatorcontrib><creatorcontrib>Mertins, Philipp</creatorcontrib><creatorcontrib>Hilfenhaus, Georg</creatorcontrib><creatorcontrib>Neumann, Christopher Claudius Maximilian</creatorcontrib><creatorcontrib>Kammertoens, Thomas</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Malinka, Thomas</creatorcontrib><creatorcontrib>Sauer, Igor Maximillian</creatorcontrib><creatorcontrib>Noessner, Elfriede</creatorcontrib><creatorcontrib>Guo, Zong Sheng</creatorcontrib><creatorcontrib>Felsenstein, Matthäus</creatorcontrib><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56 NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56 CD16 population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</description><subject>Carcinoma, Pancreatic Ductal - immunology</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Carcinoma, Pancreatic Ductal - virology</subject><subject>CD56 Antigen - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Coculture Techniques</subject><subject>Cytotoxicity, Immunologic</subject><subject>Humans</subject><subject>Interleukin-15 - metabolism</subject><subject>Interleukin-2 - metabolism</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Oncolytic Virotherapy - methods</subject><subject>Oncolytic Viruses - immunology</subject><subject>Pancreatic Neoplasms - immunology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - virology</subject><subject>Tumor Microenvironment - immunology</subject><subject>Vaccinia virus - immunology</subject><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFj11Ow0AMhFdIiJafKyBfINIuaaj6HEAcgPfKOFthuj-R1wnkONyURYVnnmakmfksn5m1s7ttY-9ctzKXpbxb61xnNxdm1e421rZuuzZf_aL5yMk3KNEPMCMRJ0aYWaYCo-SY1RegWtP8ycS6gOYPlAFGTCQelQkIpc5yRCAfQqlrBCTluaY5QT7A2xQxASf1P3cYZYH-obuHgWM17mQS6iQY4MgheDmxrs35AUPxN796ZW6fHl_652acXitpPwrHStv__dT-W_gGZWFalw</recordid><startdate>20250201</startdate><enddate>20250201</enddate><creator>Wang, Ruonan</creator><creator>Hu, Mengwen</creator><creator>Lozzi, Isis</creator><creator>Jin, Cao Zhong Jing</creator><creator>Ma, Dou</creator><creator>Splith, Katrin</creator><creator>Mengwasser, Jörg</creator><creator>Wolf, Vincent</creator><creator>Feldbrügge, Linda</creator><creator>Tang, Peter</creator><creator>Timmermann, Lea</creator><creator>Hillebrandt, Karl Herbert</creator><creator>Kirchner, Marieluise</creator><creator>Mertins, Philipp</creator><creator>Hilfenhaus, Georg</creator><creator>Neumann, Christopher Claudius Maximilian</creator><creator>Kammertoens, Thomas</creator><creator>Pratschke, Johann</creator><creator>Malinka, Thomas</creator><creator>Sauer, Igor Maximillian</creator><creator>Noessner, Elfriede</creator><creator>Guo, Zong Sheng</creator><creator>Felsenstein, Matthäus</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0003-3146-8717</orcidid></search><sort><creationdate>20250201</creationdate><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><author>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_394003173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Carcinoma, Pancreatic Ductal - immunology</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Carcinoma, Pancreatic Ductal - virology</topic><topic>CD56 Antigen - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Coculture Techniques</topic><topic>Cytotoxicity, Immunologic</topic><topic>Humans</topic><topic>Interleukin-15 - metabolism</topic><topic>Interleukin-2 - metabolism</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Oncolytic Virotherapy - methods</topic><topic>Oncolytic Viruses - immunology</topic><topic>Pancreatic Neoplasms - immunology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - virology</topic><topic>Tumor Microenvironment - immunology</topic><topic>Vaccinia virus - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Hu, Mengwen</creatorcontrib><creatorcontrib>Lozzi, Isis</creatorcontrib><creatorcontrib>Jin, Cao Zhong Jing</creatorcontrib><creatorcontrib>Ma, Dou</creatorcontrib><creatorcontrib>Splith, Katrin</creatorcontrib><creatorcontrib>Mengwasser, Jörg</creatorcontrib><creatorcontrib>Wolf, Vincent</creatorcontrib><creatorcontrib>Feldbrügge, Linda</creatorcontrib><creatorcontrib>Tang, Peter</creatorcontrib><creatorcontrib>Timmermann, Lea</creatorcontrib><creatorcontrib>Hillebrandt, Karl Herbert</creatorcontrib><creatorcontrib>Kirchner, Marieluise</creatorcontrib><creatorcontrib>Mertins, Philipp</creatorcontrib><creatorcontrib>Hilfenhaus, Georg</creatorcontrib><creatorcontrib>Neumann, Christopher Claudius Maximilian</creatorcontrib><creatorcontrib>Kammertoens, Thomas</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Malinka, Thomas</creatorcontrib><creatorcontrib>Sauer, Igor Maximillian</creatorcontrib><creatorcontrib>Noessner, Elfriede</creatorcontrib><creatorcontrib>Guo, Zong Sheng</creatorcontrib><creatorcontrib>Felsenstein, Matthäus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ruonan</au><au>Hu, Mengwen</au><au>Lozzi, Isis</au><au>Jin, Cao Zhong Jing</au><au>Ma, Dou</au><au>Splith, Katrin</au><au>Mengwasser, Jörg</au><au>Wolf, Vincent</au><au>Feldbrügge, Linda</au><au>Tang, Peter</au><au>Timmermann, Lea</au><au>Hillebrandt, Karl Herbert</au><au>Kirchner, Marieluise</au><au>Mertins, Philipp</au><au>Hilfenhaus, Georg</au><au>Neumann, Christopher Claudius Maximilian</au><au>Kammertoens, Thomas</au><au>Pratschke, Johann</au><au>Malinka, Thomas</au><au>Sauer, Igor Maximillian</au><au>Noessner, Elfriede</au><au>Guo, Zong Sheng</au><au>Felsenstein, Matthäus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2025-02-01</date><risdate>2025</risdate><volume>156</volume><issue>3</issue><spage>638</spage><pages>638-</pages><eissn>1097-0215</eissn><abstract>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56 NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56 CD16 population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</abstract><cop>United States</cop><pmid>39400317</pmid><orcidid>https://orcid.org/0000-0003-3146-8717</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1097-0215
ispartof International journal of cancer, 2025-02, Vol.156 (3), p.638
issn 1097-0215
language eng
recordid cdi_pubmed_primary_39400317
source MEDLINE; Access via Wiley Online Library
subjects Carcinoma, Pancreatic Ductal - immunology
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - pathology
Carcinoma, Pancreatic Ductal - virology
CD56 Antigen - metabolism
Cell Line, Tumor
Coculture Techniques
Cytotoxicity, Immunologic
Humans
Interleukin-15 - metabolism
Interleukin-2 - metabolism
Killer Cells, Natural - immunology
Killer Cells, Natural - metabolism
Oncolytic Virotherapy - methods
Oncolytic Viruses - immunology
Pancreatic Neoplasms - immunology
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - virology
Tumor Microenvironment - immunology
Vaccinia virus - immunology
title Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A51%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine-armed%20vaccinia%20virus%20promotes%20cytotoxicity%20toward%20pancreatic%20carcinoma%20cells%20via%20activation%20of%20human%20intermediary%20CD56%20dim%20CD16%20dim%20natural%20killer%20cells&rft.jtitle=International%20journal%20of%20cancer&rft.au=Wang,%20Ruonan&rft.date=2025-02-01&rft.volume=156&rft.issue=3&rft.spage=638&rft.pages=638-&rft.eissn=1097-0215&rft_id=info:doi/&rft_dat=%3Cpubmed%3E39400317%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/39400317&rfr_iscdi=true